Search results for Hcc Monitoring Test

Optimizing the Evaluation of Biomarkers for HCC Surveillance

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: E...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death in patients with cirrhosis. Although advancements in surgical, locoregional, and systemic therapies have i...

Abstract No. LBA15 Liquid Biopsy Detection of TP53, mGSTP1, and mRASS1Fa from Circulating Tumor DNA Improves the Non-inv...

Alpha fetoprotein (AFP) is used to screen high risk patients for hepatocellular carcinoma (HCC) but has limited sensitivity, demanding the identification of new biomarkers. This st...

Not So Fast, My Friend: Biomarkers May Play an Important Role in HCC Surveillance

Toward Precision HCC Surveillance: Standardizing Ultrasound Visualization and Optimizing Biomarker Integration

Cost-Effectiveness Analysis of Resection, Ablation and Radiation Segmentectomy for Solitary Hepatocellular Carcinoma ≤ 3...

To perform a cost-effectiveness analysis comparing liver resection, percutaneous thermal ablation (TA), and radiation segmentectomy (RS) for solitary hepatocellular carcinoma (HCC)...

DCP (Des-gamma-carboxy Prothrombin) / PIVKA-II Test

DCP (Des-gamma-carboxy Prothrombin) / PIVKA-II Test – What Is It? Why Is It Done? Ayurvedic Perspective on Liver Health Abstract ... Read more The post DCP (Des-gamma-carboxy Proth...

Abstract No. 20 Incidence and Factors Predictive of Recurrent Rupture in People with Rupture of Unresectable Hepatocellu...

Spontaneous rupture hemorrhage of hepatocellular carcinoma (HCC) has a low incidence and a high risk of death. Unresectable rupture hepatocellular (rHCC) carcinoma has a high early...

Rates of Successful Bridging or Downstaging and Safety of Segmental Radioembolization for Hepatocellular Carcinoma in Pa...

To evaluate the safety and rates of bridging or downstaging following segmental transarterial radioembolization (TARE) in hepatocellular carcinoma (HCC) patients with baseline hype...

AFP-L3 Fraction

AFP-L3 Fraction Test – What Is It? Why Is It Done? How Can Ayurvedic Herbs Help? Abstract Hepatocellular carcinoma (HCC) ... Read more The post AFP-L3 Fraction appeared first on Pl...

Radiologic Morphologies Predict Tumor Response and Patient Survival Following Chemoembolization for Single Large (> 5...

To evaluate the role of radiologic morphologies on oncologic outcomes following transarterial chemoembolization (TACE) in patients with inoperable, single large (> 5 to ≤ 10 cm)...

Abstract No. 19 Should Transarterial Chemoembolization Be Applied with Systemic Therapy for Hepatocellular Carcinoma wit...

Systemic therapy with or without radiotherapy is useful for hepatocellular carcinoma (HCC) with hepatic vein and/or inferior vena cava tumor thrombus (HVTT/IVCTT). However, the eff...

Abstract No. 359 Predictors of Hepatic Decompensation Post-Y90 Treatment in Hepatocellular Carcinoma: New Insights into...

Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality, with transarterial radioembolization (TARE) using yttrium-90 (Y90) microspheres offering viable treatment for...

Cytokeratin-18 Fragments (M30 / M65)

Cytokeratin-18 Fragments (M30 / M65) – What Is It? Why Is It Done? & Ayurvedic Hepatoprotective Herbs Abstract Chronic liver ... Read more The post Cytokeratin-18 Fragments (M3...

Abstract No. LBA10 DOORwaY90: Selective Internal Radiation Therapy using SIR-Spheres Y-90 Resin Microspheres as first-li...

DOORwaY90, a prospective, multicenter, open-label, single-arm study, evaluated the safety and efficacy of 90Y-resin microspheres as first-line treatment for local tumor control in...

Biomarker Combinations and Novel Surveillance Strategies: A "Traffic Light" Approach and Resource Optimization

Abstract No. 291 Quantitative Three-Dimensional (3D) Margin Analysis for Predicting Complete Pathologic Necrosis in Hepa...

To evaluate the association between unablated tissue volume within a pre-defined tumor margin and the achievement of complete pathologic necrosis (CPN) in hepatocellular carcinoma...

Automated EHR Alert Enhances Hepatitis B Monitoring in Primary Care Clinic

In the bustling urban landscape of St. Paul, Minnesota, an innovative transformation unfolded within a safety-net primary care clinic that sought to address a persistent challenge...

Abstract No. 356 Volume of Underdosed Tumor Predicts Survival After Radiation Segmentectomy of Hepatocellular Carcinoma...

To evaluate survival and progression outcomes among hepatocellular carcinoma (HCC) patients treated with radiation segmentectomy (RS) using resin microspheres prescribed using the...

Tracking Long-Term Viral Response Patterns and Clinical Outcomes in Hepatitis B-Related Cirrhosis

In a groundbreaking study published in the Journal of Clinical and Translational Hepatology, researchers have provided new insights into the long-term virological response patterns...

Stereotactic Percutaneous Thermal Ablation of Primary and Metastatic Liver Tumors: A Prospective Registry-Based Study

To prospectively evaluate safety, accuracy, and effectiveness of stereotactic thermal ablation of malignant liver tumors at a large academic center in the United States.

Abstract No. 501 Comparison of Same-Day Discharge and Overnight Observation Outcomes Following Percutaneous Liver Ablati...

The objective of this study is to evaluate whether the institutional transition from routine overnight observation to same-day discharge after percutaneous ablation (PA) of liver t...

Enhanced Liver Fibrosis (ELF) Test

Enhanced Liver Fibrosis (ELF) Test Explained: An Integrative Ayurvedic Perspective on Liver Health Abstract Liver fibrosis represents a dynamic process ... Read more The post Enhan...

71 MOLECULAR CLASSIFICATION AND SPATIAL CHARACTERIZATION OF INTRAHEPATIC CHOLANGIOCARCINOMA